Suppr超能文献

肝硬化腹水患者的有效血浆容量。有证据表明,有效血浆容量降低并不能解释肾钠潴留、肾小球滤过率(GFR)的自发性降低以及药物诱导利尿期间GFR的下降。

Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.

作者信息

Lieberman F L, Ito S, Reynolds T B

出版信息

J Clin Invest. 1969 Jun;48(6):975-81. doi: 10.1172/JCI106078.

Abstract

A reduction in effective (nonportal) plasma volume is considered the basis for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR occurring during drug-induced diuresis in patients with cirrhosis and ascites. In the present study the concept of a reduced effective plasma volume in cirrhosis is challenged by two lines of evidence, even though effective plasma volume itself could not be measured. (a) Total plasma volume failed to rise in 10 patients with the spontaneous loss of ascites, the appearance of sodium in the urine, and a rise in GFR. Portal pressure remained constant in these patients as ascites left, suggesting that effective plasma volume had not increased while portal plasma volume decreased. (b) Reduction of GFR could not be prevented in five patients with cirrhosis and ascites while total plasma volume was prevented from falling with albumin infusions during drug-induced diuresis. Reduction of GFR during drug-induced diuresis in 15 patients with cirrhosis and ascites was completely reversed with saline infusion despite continued diuresis with the identical drugs, excluding drug nephrotoxicity as the cause for the reduced GFR. The ascites of cirrhosis might no longer be regarded as a cause of effective plasma volume contraction, stimulating renal sodium retention and a reduction in GFR. More likely, this form of ascites is a result of plasma volume expansion and sodium retention. The causes for renal sodium retention and a spontaneous reduction in GFR remain unknown. The cause for a fall in GFR during drug-induced diuresis also remains unknown, but effective plasma volume contraction and drug nephrotoxicity seem excluded.

摘要

有效(非门静脉)血浆量减少被认为是肝硬化腹水患者肾钠潴留、肾小球滤过率(GFR)自发性降低以及药物诱导利尿期间GFR下降的基础。在本研究中,尽管无法测量有效血浆量,但有两条证据对肝硬化患者有效血浆量减少的概念提出了挑战。(a)10例自发性腹水消失、尿中出现钠且GFR升高的患者,其总血浆量未增加。随着腹水消退,这些患者的门静脉压力保持恒定,这表明当门静脉血浆量减少时,有效血浆量并未增加。(b)在药物诱导利尿期间,对5例肝硬化腹水患者输注白蛋白以防止总血浆量下降,但仍无法防止GFR降低。15例肝硬化腹水患者在药物诱导利尿期间GFR降低,尽管继续使用相同药物利尿,但输注生理盐水后GFR完全恢复正常,排除了药物肾毒性是GFR降低的原因。肝硬化腹水可能不再被视为有效血浆量收缩的原因,刺激肾钠潴留和GFR降低。更有可能的是,这种形式的腹水是血浆量扩张和钠潴留的结果。肾钠潴留和GFR自发性降低的原因仍然未知。药物诱导利尿期间GFR下降的原因也仍然未知,但有效血浆量收缩和药物肾毒性似乎可以排除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043b/322311/676e72afd0cb/jcinvest00212-0032-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验